Cargando…
Identification of Tumor Antigens and Immune Subtypes of Glioblastoma for mRNA Vaccine Development
The use of vaccines for cancer therapy is a promising immunotherapeutic strategy that has been shown to be effective against various cancers. Vaccines directly target tumors but their efficacy against glioblastoma multiforme (GBM) remains unclear. Immunotyping that classifies tumor samples is consid...
Autores principales: | Lin, Han, Wang, Kun, Xiong, Yuxin, Zhou, Liting, Yang, Yong, Chen, Shanwei, Xu, Peihong, Zhou, Yujun, Mao, Rui, Lv, Guangzhao, Wang, Peng, Zhou, Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847306/ https://www.ncbi.nlm.nih.gov/pubmed/35185876 http://dx.doi.org/10.3389/fimmu.2022.773264 |
Ejemplares similares
-
Validation of the functions and prognostic values of synapse-associated proteins in lower-grade glioma
por: Lin, Han, et al.
Publicado: (2021) -
Dissecting Tumor Antigens and Immune Subtypes of Glioma to Develop mRNA Vaccine
por: Zhong, Hua, et al.
Publicado: (2021) -
Recognition of Tumor-Associated Antigens and Immune Subtypes in Glioma for mRNA Vaccine Development
por: Ma, Shuai, et al.
Publicado: (2021) -
Exploitation of tumor antigens and construction of immune subtype classifier for mRNA vaccine development in bladder cancer
por: Zhang, Xin, et al.
Publicado: (2022) -
Tumor antigens and immune subtypes of glioblastoma: the fundamentals of mRNA vaccine and individualized immunotherapy development
por: Wu, Changwu, et al.
Publicado: (2022)